Clear cell variant of diffuse large B-cell lymphoma: A case report

Journal of Medical Case Reports

Volumn 5, Issue , 2011, Pages

  Manxhuka Kerliu, Suzana ^a   Petrusevska, Gordana ^b   Kerliu, Irma ^c   Kryeziu, Emrush ^d   Ahmeti, Fehmi ^d   Devolli Disha, Emine ^d   Sahatciu Meka, Vjollca ^d   Loxha, Sadushe ^a   Shahini, Labinot ^a  

^a UNIVERSITY OF PRISHTINA   (Serbia)

^b SS CYRIL AND METHODIUS UNIVERSITY   (Macedonia)

^c MASSACHUSETTS COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

^d UNIVERSITY CLINICAL CENTER OF KOSOVO   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIBODY; CD3 ANTIGEN; CD5 ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR; CYCLOPHOSPHAMIDE; CYTOKERATIN; CYTOKERATIN 7; DOXORUBICIN; PREDNISOLONE; PROSTATE SPECIFIC ANTIGEN; PROTEIN BCL 2; PROTEIN BCL 6; RITUXIMAB; VINCRISTINE SULFATE;

ADULT; ARTICLE; B CELL LYMPHOMA; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CERVICAL LYMPH NODE; CLEAR CELL CARCINOMA; CYTOLOGY; FATIGUE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; LYMPH NODE BIOPSY; MACROPHAGE; MALE; MITOSIS; MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

EID: 79955813938     PISSN: 17521947     EISSN: 17521947     Source Type: Journal    
DOI: 10.1186/1752-1947-5-182     Document Type: Article

References (26)

1. Advances in the biology and therapy of diffuse large B-cell lymphoma: moving toward a molecularly targeted approach. JS Abramson MA Shipp, Blood 2005 106 1164 1174 10.1182/blood-2005-02-0687 15855278 (Pubitemid 41129574)
2. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. NL Harris ES Jaffe H Stein PM Banks JK Chan ML Cleary G Delsol C De Wolf-Peeters B Falini KC Gatter, Blood 1994 84 1361 1392 8068936 (Pubitemid 24273002)
3. Diffuse large B-cell lymphoma. KC Gatter RA Warnke, Pathology Genetics of Tumours of Haematopoietic and Lymphoid Tissues: IARC WHO Classification of Tumours Lyon, France: IARC Press, Jaffe ES, Harris NL, Stein H, Vardiman JW, 3 2001 3 171 174
4. SH Swerdlow E Campo NL Harris ES Jaffe SA Pileri H Stein J Thiele JW Vardiman, WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (IARC WHO Classification of Tumours) Geneva: World Health Organization 4 2008 2
5. Diffuse large B-cell lymphoma: one or more entities? Present controversies and possible tools for its subclassification. SA Pileri S Dirnhofer P Went S Ascani E Sabattini T Marafioti A Tzankov L Leoncini B Falini PL Zinzani, Histopathology 2002 41 482 509 10.1046/j.1365-2559.2002.01538.x 12460202 (Pubitemid 36693595)
6. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. CP Hans DD Weisenburger TC Greiner RD Gascoyne J Delabie G Ott HK Müller-Hermelink E Campo RM Braziel ES Jaffe Z Pan P Farinha LM Smith B Falini AH Banham A Rosenwald LM Staudt JM Connors JO Armitage WC Chan, Blood 2004 103 275 282 10.1182/blood-2003-05-1545 14504078 (Pubitemid 38029949)
7. ALK-positive diffuse large B-cell lymphoma with the t(2;17)(p23;q23). D Zhang R Denley D Filippa J Teruya-Feldstein, Appl Immunohistochem Mol Morphol 2009 17 172 177 10.1097/PAI.0b013e31818629a8 19521280
8. De novo nodal diffuse large B-cell lymphoma: identification of biologic prognostic factors. A Abd El-Hameed, J Egypt Natl Canc Inst 2005 17 20 28 16353079
9. Prognostic biomarkers in diffuse large B-cell lymphoma. IS Lossos D Morgensztern, J Clin Oncol 2006 24 995 1007 10.1200/JCO.2005.02.4786 16418498 (Pubitemid 46638855)
10. Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. MA Shipp KN Ross P Tamayo AP Weng JL Kutok RC Aguiar M Gaasenbeek M Angelo M Reich GS Pinkus TS Ray MA Koval KW Last A Norton TA Lister J Mesirov DS Neuberg ES Lander JC Aster TR Golub, Nat Med 2002 8 68 74 10.1038/nm0102-68 11786909 (Pubitemid 34101731)
11. Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction. S Bea A Zettl G Wright I Salaverria P Jehn V Moreno C Burek G Ott X Puig L Yang A Lopez-Guillermo WC Chan TC Greiner DD Weisenburger JO Armitage RD Gascoyne JM Connors TM Grogan R Braziel RI Fisher EB Smeland S Kvaloy H Holte J Delabie R Simon J Powell WH Wilson ES Jaffe E Montserrat HK Muller-Hermelink LM Staudt E Campo A Rosenwald Lymphoma/Leukemia Molecular Profiling Project, Blood 2005 106 3183 3190 10.1182/blood-2005-04-1399 16046532 (Pubitemid 41565917)
12. Spontaneous regression of diffuse large B-cell lymphoma harbouring Epstein-Barr virus: a case report and review of the literature. R Abe K Ogawa Y Maruyama N Nakamura M Abe, J Clin Exp Hematopathol 2007 47 23 26 10.3960/jslrt.47.23
13. Survival prediction of diffuse large-B-cell lymphoma based on both clinical and gene expression information. L Li, Bioinformatics 2006 22 466 471 10.1093/bioinformatics/bti824 16339281 (Pubitemid 43231422)
14. Diffuse large B-cell lymphoma associated with chronic inflammation as incidental finding and new clinical scenarios. F Loong AC Chan BC Ho YP Chau HY Lee W Cheuk WK Yuen WS Ng HL Cheung JK Chan, Mod Pathol 2010 23 493 501 10.1038/modpathol.2009.168 20062008
15. Diffuse large B-cell lymphoma of non-germinal center B-cell type of the heart in an immunocompetent woman: an autopsy case. T Terada, Med Oncol 2011 28 201 210
16. Usefulness of immunohistochemistry in identification of prognostically important subgroups (GCB and ABC) in a heterogeneous group of diffuse large B-cell lymphomas: a review article. J Jaboska D Jesionek-Kupnicka, Pol J Pathol 2008 59 121 127 19097355
17. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. AA Alizadeh MB Eisen RE Davis C Ma IS Lossos A Rosenwald JC Boldrick H Sabet T Tran X Yu JI Powell L Yang GE Marti T Moore J Hudson Jr L Lu DB Lewis R Tibshirani G Sherlock WC Chan TC Greiner DD Weisenburger JO Armitage R Warnke R Levy W Wilson MR Grever JC Byrd D Botstein PO Brown LM Staudt, Nature 2000 403 503 511 10.1038/35000501 10676951 (Pubitemid 30082188)
18. Blimp-1 protein and Hans classification on prognosis of diffuse large B-cell lymphoma and their interrelation. Y Song Z Cao L Li HT Zhang X Zhang, Chin J Cancer 2010 29 781 786 20800019
19. Novel disease targets and management approaches for diffuse large B-cell lymphoma. WH Wilson FJ Hernandez-Ilizaliturri K Dunleavy RF Little OA O'Connor, Leuk Lymphoma 2010 51 Suppl 1 1 10 20658952
20. Recent prognostic factors in diffuse large B-cell lymphoma indicate NF-B pathway as a target for new therapeutic strategies. A Pavan M Spina V Canzonieri S Sansonno G Toffoli Re V De, Leuk Lymphoma 2008 49 2048 2058 10.1080/10428190802444176 19021048
21. [Clinicopathologic significance of bcl-6 gene rearrangement and expression in three molecular subgroups of diffuse large B-cell lymphoma] [in Chinese]. FP Xu YH Liu XL Luo HG Zhuang L Li DL Luo J Xu F Zhang MH Zhang X Du WY Li, Zhonghua Bing Li Xue Za Zhi 2008 37 371 376 19031715
22. Clinicopathologic significance of immunophenotypic profiles related to germinal center and activation B-cell differentiation in diffuse large B-cell lymphoma from Chinese patients. YH Liu FP Xu HG Zhuang KC Lai D Xie DL Luo L Li XL Luo J Xu MH Zhang F Zhang HM Li, Hum Pathol 2008 39 875 884 10.1016/j.humpath.2007.10.013 18440593
23. Favorable outcome of primary mediastinal large B-cell lymphoma in a single institution: the British Columbia experience. KJ Savage N Al-Rajhi N Voss C Paltiel C Klasa RD Gascoyne JM Connors, Ann Oncol 2006 17 123 130 10.1093/annonc/mdj966 16236753 (Pubitemid 43033851)
24. A significant diffuse component predicts for inferior survival in grade 3 follicular lymphoma, but cytologic subtypes do not predict survival. CP Hans DD Weisenburger JM Vose LM Hock JC Lynch P Aoun TC Greiner WC Chan RG Bociek PJ Bierman JO Armitage, Blood 2003 101 2363 2367 10.1182/blood-2002-07-2298 12424193 (Pubitemid 36302082)
25. Burkitt lymphoma versus diffuse large B-cell lymphoma: a practical approach. C Bellan L Stefano F Giulia de EA Rogena L Lorenzo, Hematol Oncol 2010 28 53 56 19844983
26. Gray zones around diffuse large B cell lymphoma: conclusions based on the workshop of the XIV meeting of the European Association for Hematopathology in Bordeaux, France. L Quintanilla-Martinez D de Jong A de Mascarel ED Hsi P Kluin Y Natkunam M Parrens S Pileri G Ott, J Hematop 2009 2 211 236 10.1007/s12308-009-0053-9 20309430